encoded by the IL12A gene on chromosome 3 and the IL12B gene on chromosome 5, respectively. Recently, a polymorphism (an A/C transition) was reported at position 1188 in the 3'-untranslated region of IL-12 p40 gene 13 and the A/A genotype was reported as associated with both type 1 diabetes mellitus 14 and multiple sclerosis. 15 However, because the association between this polymorphism and atherosclerotic diseases, such as CAD, has not yet been elucidated, we investigated its frequency in 555 patients undergoing coronary angiography for suspected CAD.
Chlamydia pneumoniae (CP), one of the common human respiratory pathogens, has been often reported in seroepidemiological studies as associated with CAD; [16] [17] [18] however, its contribution to CAD remains controversial. 19, 20 The inflammatory response to CP infection may vary from person to person, and only certain individuals may develop CAD. We previously investigated CP seropositivity and IL-1 (a C/T transition at -511) and IL-1 receptor antagonist (IL-1Ra) (a variable number repeat in intron 2) gene polymorphisms in patients undergoing coronary angiography. 21 We showed a stepwise increase in the prevalence of CAD depending on a positive interaction between CP seropositivity and IL-1 gene variants (IL-1 C/C genotype and/or IL-1Ra 2-or 3-repeat allele). To examine whether or not IL-12 p40 polymorphism may have some effect on the development of CAD associated with CP infection, we also evaluated the serum CP-specific IgG titer as an indicator of the history of CP infection. 
Methods

Study Patients
The study group comprised 555 consecutive Japanese patients (427 males; mean age 63±9 years) who underwent coronary angiography for suspected CAD at the National Defense Medical College Hospital. Patients with a history of coronary artery bypass surgery were excluded. Of the 555 patients, 331 (60%) had hypertension (blood pressure ≥140/90 mmHg or medication), 228 (41%) had hyperlipidemia (total cholesterol concentration >240 mg/dl or medication), 160 (29%) had diabetes mellitus (fasting glucose concentration ≥126 mg/dl or on hypoglycemic drugs or insulin), and 369 (66%) were smokers (≥5 cigarettes/day). Our study, in which genetic analysis was performed, was approved by the ethics committee of the hospital. After written informed consent was obtained, fasting blood samples were taken on the morning of the day that coronary angiography was performed.
Coronary Angiography
Coronary angiograms were recorded by a femoral approach using the Judkins technique and a cineangiogram system (Toshiba, Tokyo, Japan). All angiograms were evaluated by one of our team (Y.M.) who was unaware of the genotype data. CAD was defined as at least 1 coronary artery with >50% luminal diameter stenosis. Myocardial infarction (MI) was confirmed by documented coronary artery stenosis plus either elevated cardiac enzymes or diagnostic changes on electrocardiogram. The severity of CAD was represented as the number of >50% stenotic vessels and the number of >50% stenotic segments. Moreover, the number of mildly stenotic segments (≤50%) and the number of diffusely stenotic segments (>10 mm) were also evaluated. The coronary artery segments were defined according to the Coronary Artery Surgery Study classification.
Genotyping and CP Serology
We used the Invader assay to analyze IL-12 p40 polymorphism because it combines structure-specific cleavage enzymes and a universal fluorescent resonance energy transfer (FRET) system. 22 After genomic DNA was extracted from the blood samples, the region (233 bp) containing the polymorphic site was amplified by polymerase chain reaction (PCR), as reported by Hall et al 13 and the PCR products were used for the assay according to our protocol. 23 The primary probes (probe 1 for the A allele, cgcgccgaggAGATGCTAAATGCTCATTGA, and probe 2 for the C allele, acggacgcggagCGATGCTAAA TGCTCATTG) and the Invader probe (CTTTAAAA CGTTTTT TTAGGATCACAATGATATCTTTGCTGTA TTTGTATAGTTT) were designed using the Invader Creator software package to obtain a theoretical annealing temperature of 63°C and 77°C, respectively. After putting the probes, PCR products and MgCl2 into the reaction wells of the FRET detection plates, they were incubated at 63°C for 0.5-2 h in a thermal cycler. The fluorescent intensities of FAM dye (A allele) and RED dye (C allele) in each well were measured using Cytoflour 4000 fluorescence plate reader (Applied Biosystems, Foster City, CA, USA) for genotyping. The concordance rate of genotyping between the Invader assay and the PCR-restriction fragment length polymorphism analysis was 100% for 980 samples in our previous reports. 23, 24 The serum CP-specific IgG titer was measured using an enzyme-linked immunosorbent assay with a commercially available kit (HITAZYME CP TM, Hitachi Chemical, Japan). This assay used the CP outer membrane complex as a CP-specific antigen. The cut off index of ≥1.10 is considered to be seropositive.
Statistical Analysis
Differences between 2 groups were evaluated by unpaired t-test for continuous variables and by chi-square test for categorical variables. Differences among 3 or more groups were evaluated by ANOVA with Scheffe's test for continuous variables and by chi-square test for categorical variables. Multiple logistic regression analysis was used to elucidate any association between the polymorphism and CAD. A p-value <0.05 was considered to be statistically significant. Results are presented as the mean value ± SD.
Results
Clinical Characteristics and IL-12 p40 Polymorphism
Of the 555 study patients, 395 (71%) had CAD, of whom 161 also had a MI. Compared with the 160 patients without CAD, those with CAD were older, predominantly male, had higher rates of hypertension, hyperlipidemia, diabetes and smoking, and also had lower high-density lipoprotein-cholesterol concentrations ( Table 1) . As for the IL-12 p40 polymorphism, the percentages of patients having A/A, A/C, and C/C genotypes were 23%, 48%, and 29%, respectively, a genotype distribution that did not deviate from the Hardy-Weinberg equilibrium. The percentage of patients who had the A/A genotype did not differ between patients with and without CAD (23% vs 23%, p= NS) ( Table 1 ). The frequency of the A allele was also similar in patients with and without CAD (47% vs 45%, p= NS). Moreover, there was no substantial difference in the frequencies of the A/A genotype (22% vs 23%) and the A allele (44% vs 49%) (p= NS) between CAD patients with and without MI. To test the independent association between the A/A genotype and CAD or MI, clinical variables were entered into a multivariate logistic regression model, but the A/A genotype was not an independent factor associated with either CAD or MI (Table 2) .
Table 3 Clinical Characteristics and Angiographic Findings of Patients With the A/A, A/C or C/C Genotype
A/A A/A A/C A/C C/C C/C (n=125) vs A/C (n=268) vs C/C (n=162) vs
IL-12 p40 Polymorphism and the Severity of CAD
To test the association between IL-12 p40 polymorphism and the severity of CAD, the 555 study patients were divided into 3 groups according to their genotypes: 125 with the A/A genotype, 268 with A/C genotype, and 162 with C/C genotype. Although the rate of males with the A/A genotype was high, the prevalence of CAD or MI was not higher in patients with the A/A genotype than in those with the A/C or C/C genotype ( Table 3 ). The percentage of patients who had class II or III unstable angina, as defined by Braunwald's classification, 25 was also similar among the 3 groups. Regarding the severity of CAD, the numbers of >50% stenotic vessels and >50% stenotic segments did not differ among the 3 groups. Moreover, the number of mildly stenotic segments (≤50%) and the prevalence of diffuse lesion (>10 mm) were also similar.
Interaction Between IL-12 p40 Polymorphism and CP Seropositivity
The prevalence of CP IgG seropositivity did not significantly differ between patients with and without CAD (63% vs 59%) ( Table 1) . To clarify the effect of IL-12 p40 polymorphism on CAD associated with CP infection, the 555 study patients were divided into 4 groups according to the presence or absence of CP seropositivity and/or A/A genotype: 157 with neither, 273 with CP seropositivity alone, 55 with A/A genotype alone, and 70 with combined A/A genotype and CP seropositivity. The prevalence of CAD did not differ among the 4 groups: 68%, 73%, 73% and 70% respectively (p= NS) ( Table 4 ). The prevalence of MI was also similar in the 4 groups: 27%, 31%, 29% and 27%, respectively (p= NS). The numbers of >50% stenotic vessels and >50% stenotic segments did not differ among the 4 groups. In a multivariate analysis, the A/A genotype was not an independent factor for CAD or MI in either group of patients with or without CP seropositivity.
Discussion
In 2001, polymorphism of the 3'-untranslated region of IL-12 p40 gene (the A/A genotype) was reported to be associated with type 1 diabetes 14 and multiple sclerosis. 15 The A/A genotype was shown to be associated with increased IL-12 expression in vitro, 14 but recent studies failed to show such an association between this polymorphism and diabetes 26, 27 or multiple sclerosis. 28 However, the functional effect of this polymorphism on IL-12 expression remains contradictory. 26, 29 The polymorphism has also been reported as associated with psoriasis vulgaris and atopic dermatitis. 30 In type 2 diabetes, patients with the A/A genotype have been shown to have higher plasma concentrations of oxidized low-density lipoprotein than those with the A/C or C/C genotype. 31 In our investigation of the association between the polymorphism and CAD in 555 patients who underwent coronary angiography the frequency did not differ between patients with and without CAD, nor was an association found between this polymorphism and the severity of CAD.
Seroepidemiological studies have reported that CP infection is associated with CAD [16] [17] [18] and CP organisms have been detected within atheroma. 32, 33 CP infection was demonstrated to accelerate atherosclerosis in a rabbit model; 34 however, the potential contribution of CP infection to CAD remains controversial. Two prospective studies failed to show any association between CP seropositivity and CAD, 19, 20 nor did we find any significant association between CP seropositivity and CAD in the present study. The inflammatory response to CP infection may vary from person to person, and only certain individuals may develop CAD. We previously investigated CP seropositivity and IL-1 (C/T at -511) and IL-1Ra (a variable number repeat) gene polymorphisms in 292 patients undergoing coronary angiography. 21 We demonstrated a stepwise increase in the prevalence of CAD depending on the positive interaction between CP seropositivity and IL-1 gene variants (IL-1 C/C genotype and/or IL-1Ra 2-or 3-repeat allele), and the highest CAD prevalence was seen in patients with combined variants and seropositivity. Moreover, IL-1 gene variants were found to be associated with MI only in patients with CP seropositivity. However, in the present study, no such interaction between CP seropositivity and IL-12 p40 polymorphism was found, and the prevalence of CAD or MI did not differ among the 4 groups divided by the presence or absence of CP seropositivity and/or A/A genotype. Our results suggest that IL-12 p40 polymorphism is unlikely to influence the susceptibility to CAD associated with CP infection.
Study Limitations
First, our study is cross-sectional and as such cannot establish causality. It only shows some association and is hypothesis-generating. Second, we did not have healthy controls. Patients undergoing angiography are generally considered to be a highly selected population at high-risk for CAD. This may have caused some selection bias and confounded the results. Third, our study was in the Japanese population and so the results may not be applicable to other ethnic populations.
Conclusion
IL-12 p40 polymorphism was not found to be associated with the presence or severity of CAD, which suggests that it does not play an important role in the development of CAD. However, to fully elucidate its effect on the development of CAD, a further prospective study is needed in a large population.
